InMode
Irvine, California, Israel · Biotechnology, Health Care, Manufacturing
InMode develops, manufactures, and markets medical devices based on radiofrequency technology. Its products are used across plastic surgery, dermatology, gynecology, otolaryngology, and ophthalmology applications. Founded in Israel, the company is focused on supporting long-term strategic priorities and governance initiatives. InMode has a strong financial foundation and a commitment to shareholde
Key facts
- Headquarters
- Irvine, California, Israel
- Employees
- 600
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (INMD)
- Website
- inmodemd.com
- Company page
Recent activity at InMode
Leadership
- Moshik Itzkovich, Chief Financial Officer
- Michael Dennison, President
Verified email and direct lines for InMode’s decision-makers are on Fundz. See plans
InMode in the news
- InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - PR Newswire (Apr 13, 2026)
- InMode Responds to Transaction Rumors - PR Newswire (Feb 02, 2026)
- InMode to Report Third Quarter 2019 Financial Results on November 5, 2019 - Lelezard (Oct 10, 2019)
- InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase - PR Newswire (May 06, 2026)
- InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million - PR Newswire (Feb 10, 2026)
- InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease - PR Newswire (Apr 28, 2025)
- InMode Reports Record Second Quarter 2021 Financial Results: Quarterly Revenues of $87.3 Million Represent 184% Year Over Year Growth - PR Newswire (Jul 28, 2021)
- InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth - PR Newswire (May 05, 2021)
Companies similar to InMode
- Anteris Technologies · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
- PROTEOR · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
- IceCure Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
- Andersen Sterilizers · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
- Ronovo Surgical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
About InMode: questions and answers
What does InMode do?
InMode develops, manufactures, and markets medical devices based on radiofrequency technology. Its products are used across plastic surgery, dermatology, gynecology, otolaryngology, and ophthalmology applications. Founded in Israel, the company is focused on supporting long-term strategic priorities and governance initiatives. InMode has a strong financial foundation and a commitment to shareholde
Where is InMode headquartered?
InMode is headquartered in Irvine, California, Israel.
How many employees does InMode have?
InMode has about 600 employees.
Who leads InMode?
Michael Dennison is a President at InMode.
What is the latest news on InMode?
On May 20, 2026, InMode Appoints Moshik Itzkovich as Chief Financial Officer
Is InMode a public company?
Yes. InMode is publicly traded under the ticker INMD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy